OUR PRODUCTS

C-peptide

PRODUCT NAME: ST AIA-PACK C-Peptide
INTENDED USE: ST AIA-PACK C-Peptide is designed for IN-VITRO DIAGNOSTIC USE for the quantitative measurement of C-peptide in human serum and heparinized plasma, EDTA plasma or urine on Tosoh AIA immunoassay analyzers.
SUMMARY AND EXPLANATION OF TEST: C-peptide originates from pancreatic β-cell as a metabolically by-product in the synthesis of insulin from proinsulin. One molecule of C-peptide is formed as one molecule of insulin is formed, hence measuring the level of C-peptide can ascertain insulin secretion ability. It is possible to estimate the level of endogenous insulin secretion in diabetes patients on insulin therapy by measuring the level of C-peptide. Anti-insulin antibodies are commonly found in patients who have undergone insulin therapy. These circulating anti-insulin antibodies may interfere with certain immunoassays for insulin, making it difficult to use as a measure of residual β-cell activity. C-peptide measurement is therefore used as an alternative measurement index in this context. C-peptide measurement is also used as an additional means of evaluating glucose tolerance tests.
TECHNICAL SPECIFICATIONS:
Method: Enzyme Immunoassay (EIA)
Principle: Two-site immunoenzymometric assay
Calibrators: 0, 0.5, 2, 6, 15, 33  ng/mL
Assay sample: Serum and heparinized plasma, urine
Assay range: 0.2 - 30  ng/mL
Reaction time: 10 minutes
Storage: 2 - 8 ºC
Kit Contents: ST AIA-PACK C-Peptide
Consumables: AIA-PACK SUBSTRATE SET II
AIA-PACK C-Peptide CALIBRATOR SET
AIA-PACK C-Peptide SAMPLE DILUTING SOLUTION
AIA-PACK WASH CONCENTRATE
AIA-PACK DILUENT CONCENTRATE
AIA-PACK DETECTOR STANDARDIZATION TEST CUP
AIA-PACK SAMPLE TREATMENT CUP
SAMPLE CUPS

*Please refer to the product Instruction-For-Use (IFU) for complete details.

0.2 - 200 mIU/mL